A point mutation at another site on BRCA2, D2723H, is cancer-prone and leads to cytoplasmic mis-localization of BRCA2 due to wrongly exposed nuclear export signals as a consequence of defective DSS1 binding [48]. The gene discussed is BRCA2; the disease is cancer.